Status:
COMPLETED
Hepatic Impairment Study
Lead Sponsor:
Bayer
Conditions:
Liver Disease
Eligibility:
All Genders
50-75 years
Phase:
PHASE1
Brief Summary
This study is to find out how the subject's body processes and reacts to the study drug, and to find out how long it remains in the subjects system after one dose. Subjects with varying degrees of liv...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Healthy Subjects, Child Pugh A and Child Pugh B Liver Disease Patients.
Exclusion
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2009
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT00829231
Start Date
January 1 2009
End Date
July 1 2009
Last Update
November 3 2014
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Miami, Florida, United States, 33014
2
Orlando, Florida, United States, 32809
3
Knoxville, Tennessee, United States, 37920